Jamson Pharmaceutical Private Limited - Due diligence report

A 360° intelligence report on Jamson Pharmaceutical Private Limited: trust score, financial health, credit view, compliance, directors, grow…

2011-08-30 Indore, Madhya Pradesh Strike Off Unlisted Active Compliant
Connect MCP
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Jamson Pharmaceutical Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
62/100
Trust Score
Moderate

Jamson Pharmaceutical Private Limited is assessed as Moderate with a Trust Score of 62/100. Jamson Pharmaceutical Private Limited is a private limited indian non-government company incorporated in 2011, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 30 Oct 2026 from the latest processed filings. Jamson Pharmaceutical Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Caution

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
62/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
23/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
50/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
45/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 50/100 Moderate
  • Liabilities ≈ 38% EBITDA - stretched.
  • No open charges - unencumbered balance sheet.
  • Elevated gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 23/100 Caution Indicated
  • Company status is "Strike Off" - not Active.
  • Last balance sheet is for Mar 2018 - filings overdue.
  • Litigation present in 1 court forum(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
ASHISH SHRIVASTAVA 01234567 Director 01/04/2018 6 yrs Approved
SUNIL KUMAR JOSHI 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2018 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 45
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Asset base grew 61% - capacity expansion.
Net margin improved to 38%.
Operating for 15+ years.
Active EPFO - real payroll on record.
Distress signals & risk flags
Outside liabilities up 1.42 in a year.
Statutory filings appear overdue.
Adverse company status: Strike Off.
Compliance score is weak (23/100).
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence41/100
Caution indicated
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment52/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view82/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 5 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 13 events
30 Sep 2018
Last AGM held
Annual general meeting
31 Mar 2018
Latest balance sheet
Filed with ROC
26 Mar 2018
Director ceased
REKHA SHRIVASTAVA
Director ceased
SUBHASH MANOCHA
06 Aug 2015
Securities allotted
137500 Equity Shares Without Differential Rights - 13.75 Lakh raised
23 Oct 2013
Securities allotted
82500 Equity Shares Without Differential Rights - 8.25 Lakh raised
16 Sep 2013
Director appointed
ASHISH SHRIVASTAVA (Director)
Director appointed
SUNIL KUMAR JOSHI (Director)
Director ceased
AMIT MANOCHA
25 Jul 2012
Director ceased
RASHMI SHRIVASTAVA
Director ceased
DIPALI MAHAJAN
15 Nov 2011
Director ceased
MEGHA SHALIGRAM
30 Aug 2011
Incorporated
Registered with Roc Gwalior
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
2 active director(s) / partner(s); board looks stable and experienced.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2018 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Dr. Gandhi'S Laboratory Private Limited U24233WB2014PTC199780 Uluberia, West Bengal, India
Catalyst Speciality Chemicals Private Limited U24100MH2012PTC258448 Mumbai, Maharashtra, India
Rana Minchem India Private Limited U14108RJ2011PTC036786 Parbatsar, Rajasthan, India
Eshwar Pharmaceuticals Private Limited U24232TG2008PTC059164 Hyderabad, Telangana, India
Surchem Mv Chemicals Private Limited U52190MH2013PTC249411 Mumbai, Maharashtra, India
Sanova Pharma Chem Private Limited U24232TG2007PTC052453 Hayathnagar, Telangana, India
Tribology India Limited L24294TN1984PLC010692 -
Biokemix U24110TG2006PLC049500 Begumpet Hyderabad,, Telangana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Jamson Pharmaceutical Private Limited before audits and certifications: compliance score 23/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Jamson Pharmaceutical Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Jamson Pharmaceutical Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Caution indicated. Trust score 62/100, distress signals and MSME payment-delay disclosures - know whether Jamson Pharmaceutical Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Jamson Pharmaceutical Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Jamson Pharmaceutical Private Limited an active company?

Jamson Pharmaceutical Private Limited has MCA status “Strike Off” with a compliance score of 23/100 (Caution Indicated).

Is Jamson Pharmaceutical Private Limited financially healthy?

Jamson Pharmaceutical Private Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Jamson Pharmaceutical Private Limited?

Its overall Trust Score is 62/100 (Moderate). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Jamson Pharmaceutical Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Jamson Pharmaceutical Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Jamson Pharmaceutical Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2018 - filings overdue. Overall compliance score: 23/100 (Caution Indicated).

Is it risky to lend to Jamson Pharmaceutical Private Limited?

Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.